#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13220	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2090	629.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1693	1693	T	764	T	698	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13220	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2090	629.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1427	1427	C	746	C	687	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23996	23S	2890	2890	99.97	23S.l6.c4.ctg.1	3553	673.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2333	2333	C	760	C,T	699,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23996	23S	2890	2890	99.97	23S.l6.c4.ctg.1	3553	673.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2407	2407	A	758	A	709	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23996	23S	2890	2890	99.97	23S.l6.c4.ctg.1	3553	673.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2959	2959	C	741	C	691	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	111976	blaTEM	861	861	99.77	blaTEM.l6.c30.ctg.1	1640	5152.3	0	.	p	.	0	M180T	NONSYN	538	540	ATG	901	903	ACG	7944;7917;7925	A;C,T;G,A	7491;7537,1;7531,1	.	Betalactam resistance
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	111976	blaTEM	861	861	99.77	blaTEM.l6.c30.ctg.1	1640	5152.3	0	.	p	.	0	A222T	NONSYN	664	666	GCC	1027	1029	ACC	7320;7326;7339	ACCC,ACCCC;C,T,A;C,T	4778,9;5467,2,1;6085,1	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1868	folP	855	855	100.0	folP.l15.c4.ctg.1	1329	139.1	1	SNP	p	R229S	1	.	.	685	687	AGC	928	930	AGC	179;178;178	A;G;C	165;165;163	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4830	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3284	146.7	1	SNP	p	S91F	1	.	.	271	273	TTC	532	534	TTC	156;156;157	T;T;C	145;144;144	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4830	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3284	146.7	1	SNP	p	D95G	1	.	.	283	285	GGC	544	546	GGC	160;161;162	G;G;C	149;147;149	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4830	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3284	146.7	1	SNP	p	G95N	0	.	.	283	285	GGC	544	546	GGC	160;161;162	G;G;C	149;147;149	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	539	1336	mtrR	633	633	99.37	mtrR.l15.c30.ctg.1	1348	98.8	0	.	p	.	0	A39T	NONSYN	115	117	GCC	471	473	ACC	157;157;156	A,G;C;C	141,1;143;144	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	764	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1035	73.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4280	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2965	144.1	0	.	p	.	0	E91G	NONSYN	271	273	GAG	588	590	GGG	162;164;164	G;G;G	153;157;154	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4280	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2965	144.1	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1467	1469	ATC	178;177;173	A;T;C	160;163;160	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4280	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2965	144.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1620	1622	GCA	155;156;159	G;C;A	142;138;136	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4280	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2965	144.1	1	SNP	p	D86N	0	.	.	256	258	GAC	573	575	GAC	165;166;170	G;A;C	151;150;155	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4280	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2965	144.1	1	SNP	p	S87R	0	.	.	259	261	AGT	576	578	AGT	167;166;165	A;G;T	156;157;154	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4280	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2965	144.1	1	SNP	p	S87I	0	.	.	259	261	AGT	576	578	AGT	167;166;165	A;G;T	156;157;154	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4280	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2965	144.1	1	SNP	p	S87W	0	.	.	259	261	AGT	576	578	AGT	167;166;165	A;G;T	156;157;154	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4280	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2965	144.1	1	SNP	p	S88P	0	.	.	262	264	TCC	579	581	TCC	163;163;163	T;C;C	153;154;154	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4038	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2604	154.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1530	1532	GGC	219;217;215	G;G;C	204;201;197	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	3808	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2447	155.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1287	1289	GCA	212;212;210	G;C;A	196;197;195	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3808	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2447	155.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1290	1292	ATC	209;208;208	A;T;C	192;196;196	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3808	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2447	155.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1302	1304	GTG	203;205;205	G;T;G	192;192;193	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3808	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2447	155.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1302	1304	GTG	203;205;205	G;T;G	192;192;193	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3808	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2447	155.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1806	1808	ACC	182;184;184	A;C;C	156;162;158	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3808	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2447	155.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1860	1862	GCG	166;162;161	G,C;C,G;G	138,1;129,1;131	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3808	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2447	155.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1860	1862	GCG	166;162;161	G,C;C,G;G	138,1;129,1;131	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3808	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2447	155.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1983	1985	GGC	167;166;165	G;G;C	147;145;144	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3808	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2447	155.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1992	1994	GGC	153;152;151	G;G;C	130;131;128	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3808	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2447	155.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2010	2012	CCG	120;121;126	C,G;C;G	82,5;84;90	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5236	ponA	2397	2397	99.92	ponA.l6.c30.ctg.1	3062	170.8	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1477	1479	ACG	183;182;178	A;C,A;G	168;166,1;166	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5236	ponA	2397	2397	99.92	ponA.l6.c30.ctg.1	3062	170.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1615	1617	CCG	201;201;200	C;C;G	170;178;169	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1970	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1599	122.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	258	260	GGC	147;146;146	G,A;G;C	134,1;134;134	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1970	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1599	122.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	440	440	C	147	C	133	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	539	2654	porB1a	984	984	99.49	porB1a.l15.c17.ctg.1	1520	174.0	0	.	p	.	0	S38A	NONSYN	112	114	TCT	503	505	GCT	225;224;227	G;C;T	209;206;207	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	539	2654	porB1a	984	984	99.49	porB1a.l15.c17.ctg.1	1520	174.0	0	.	p	.	0	F195S	NONSYN	583	585	TTC	974	976	TCC	223;225;223	T;C;C	203;209;209	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	539	2654	porB1a	984	984	99.49	porB1a.l15.c17.ctg.1	1520	174.0	0	.	p	.	0	I208V	NONSYN	622	624	ATT	1013	1015	GTT	246;243;244	G;T,C;T	226;221,1;225	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10036	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4831	207.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2021	2023	AAT	208;207;209	A;A;T	195;193;192	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1078	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1034	103.8	1	SNP	p	V57M	1	.	.	169	171	ATG	531	533	ATG	216;219;217	A,G;T;G	205,1;209;206	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	528	8	tetM	1920	190	99.47	tetM.l15.c4.ctg.1	190	2.7	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	38	40	GAA	1;1;1	G;A;A	1;1;1	.	Tetracycline resistance
